Birja bozori, bugungi kunda birja
Real vaqtda 71229 ta kompaniyaning aktsiya bahosi.
Birja bozori, bugungi kunda birja

Qimmatli qog'ozlar

Aktsiya bahosi onlayn

Qimmatli qog'ozlar tarixidagi yozuvlar

Fond bozorining kapitallashuvi

Qimmatli Qimmatli Qog'ozlar

Kompaniya aktsiyalaridan olinadigan foyda

Moliyaviy hisobotlar

Kompaniyalarning aktsiyalarini baholash. Pulni qayerda sarflash kerak?

Bristol-Myers Squibb Company PFD CONV 2 aktsiyalari bahosi tarixi

Aksiya narxiBristol-Myers Squibb Company PFD CONV 2 yilda dollar grafik savdoning boshlanishidan beri. Bristol-Myers Squibb Company PFD CONV 2 qiymat tarixi yilda AQSh dollar chunki 2003.
Vidjetlarga qo'shilsin
Vidjetlarga qo'shildi

Bristol-Myers Squibb Company PFD CONV 2 valyuta zaxiralari yilda dollar narxlari tarixi, grafik savdoning boshlanishidan beri

Bristol-Myers Squibb Company PFD CONV 2 aktsiyalarining qiymati haftasiga 0% ga o'zgartirildi. O'tgan oyda Bristol-Myers Squibb Company PFD CONV 2 ning qimmatli qog'ozlari -4.167% gacha o'zgargan. O'tgan chorakda BMYMP ning aktsiyalar bahosidagi o'zgarish -2.377% tani tashkil etdi. Yil va 3 yil mobaynida Bristol-Myers Squibb Company PFD CONV 2 aktsiyalarining bahosi o'z navbatida -6.773% va +15% ga o'zgartirildi.

Ko'rsatish:
Uchun

Bristol-Myers Squibb Company PFD CONV 2 AQSh dollar qiymat tarixi

 
Sana Narx
2023 From 1 149 Uchun 1 225 USD
2022 From 1 100.530 Uchun 1 900 USD
2021 From 999.5 Uchun 2 000 USD
2020 From 800 Uchun 1 395.850 USD
2019 From 800 Uchun 1 249.780 USD
2018 From 882.65 Uchun 1 306.550 USD
2017 From 887.56 Uchun 1 050 USD
2016 From 900 Uchun 1 231.900 USD
2015 From 993.02 Uchun 1 182.590 USD
2014 From 750 Uchun 1 072.280 USD
2013 From 566.1 Uchun 884.57 USD
2011 From 570.1 Uchun 570.1 USD
2010 From 400 Uchun 570 USD
2009 From 371.61 Uchun 525 USD
2008 From 500 Uchun 500 USD
2007 From 430 Uchun 503 USD
2006 From 318 Uchun 430 USD
2005 From 364 Uchun 485 USD
2004 From 485 Uchun 525 USD
2003 From 429.5 Uchun 429.5 USD

Bristol-Myers Squibb Company PFD CONV 2 aksiyalarining qiymati

Moliya Bristol-Myers Squibb Company PFD CONV 2